Literature DB >> 32997752

ABO Blood Group Correlations with Covid-19: Cohort Choice Makes A Difference.

Daniele Focosi1, Iorio Maria Carla1, Maria Lanza1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 32997752      PMCID： PMC7543376          DOI： 10.1093/cid/ciaa1495

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer.

Authors:  Daniele Focosi; Alfredo Rosellini; Pietro Giorgio Spezia; Lisa Macera; Maria Lanza; Aldo Paolicchi; Denise Biagini; Andreina Baj; Mauro Pistello; Fabrizio Maggi
Journal:  J Clin Virol Plus       Date:  2021-08-08

Review 2.  ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data.

Authors:  Jacques Le Pendu; Adrien Breiman; Jézabel Rocher; Michel Dion; Nathalie Ruvoën-Clouet
Journal:  Viruses       Date:  2021-01-22       Impact factor: 5.048

3.  Low Levels of Natural Anti-α-N-Acetylgalactosamine (Tn) Antibodies Are Associated With COVID-19.

Authors:  Adrien Breiman; Nathalie Ruvoën-Clouet; Marie Deleers; Tiffany Beauvais; Nicolas Jouand; Jézabel Rocher; Nicolai Bovin; Nathalie Labarrière; Hanane El Kenz; Jacques Le Pendu
Journal:  Front Microbiol       Date:  2021-02-11       Impact factor: 5.640

4.  Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation.

Authors:  Herbert F Jelinek; Mira Mousa; Nawal Alkaabi; Eman Alefishat; Gihan Daw Elbait; Hussein Kannout; Hiba AlHumaidan; Francis Amirtharaj Selvaraj; Hala Imambaccus; Stefan Weber; Maimunah Uddin; Fatema Abdulkarim; Bassam Mahboub; Guan Tay; Habiba Alsafar
Journal:  Front Med (Lausanne)       Date:  2022-01-13

5.  SARS-CoV-2 and mutation RT-qPCR test positivity correlation with ABO and Rh blood types.

Authors:  Burcu Gürer Giray; Gökçe Güven Açık
Journal:  J Med Virol       Date:  2022-06-14       Impact factor: 20.693
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.